5 Results for "

hGAT3

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "hGAT3" in MCE Product Catalog:

Cat. No.: HY-103506
CAS No.: 145645-62-1
Pureté:  99.76%
Synonyms: NO-711 hydrochloride
Target:  

GABA Receptor

Domaines de recherche:  

Neurological Disease

NNC-711 (NO-711 hydrochloride) is a potent and selective inhibitor of GAT-1 (GABA transporter 1) with IC50 values of 0.04, 0.38, 171, 1700, 349, 622 μM for human GAT-1, rat GAT-1, rGAT-2, hGAT-3, rGAT-3, hBGT-3, respectively. NNC-711 has anticonvulsant and analgesic effect in vivo and exhibits cognition-enhancing activity [3] .
loading...
    loading...
Cat. No.: HY-135482
CAS No.: 1781880-44-1
Target:  

GABA Receptor

Domaines de recherche:  

Neurological Disease

GABAA receptor agent 2 TFA is a potent and high-affinity GABAA receptor antagonist with an IC50 of 24 nM (human α1β2γ2 GABAA-expressing tsA201 cells) and a Ki of 28 nM (rat GABAA receptors). GABAA receptor agent 2 TFA is inactive against four human GABA transporters (hGAT-1, hBGT-1, hGAT-2, and hGAT-3) .
loading...
    loading...
Cat. No.: HY-103504R
CAS No.: 157604-55-2
Domaines de recherche:  

Neurological Disease

(S)-SNAP5114 (Standard) is the analytical standard of (S)-SNAP5114 (HY-103504). This product is intended for research and analytical applications. (S)-SNAP5114 is a selective GABA transport inhibitor, with IC50 values of 5 μM and 21 μM for hGAT-3 and rGAT-2, respectively. (S)-SNAP5114 is an anticonvulsant agent .
loading...
    loading...
Cat. No.: HY-103506R
CAS No.: 145645-62-1
Synonyms: NO-711 hydrochloride (Standard)
Domaines de recherche:  

Neurological Disease

NNC-711 (Standard) is the analytical standard of NNC-711 (HY-103506). This product is intended for research and analytical applications. NNC-711 (NO-711 hydrochloride) is a potent and selective inhibitor of GAT-1 (GABA transporter 1) with IC50 values of 0.04, 0.38, 171, 1700, 349, 622 μM for human GAT-1, rat GAT-1, rGAT-2, hGAT-3, rGAT-3, hBGT-3, respectively. NNC-711 has anticonvulsant and analgesic effect in vivo and exhibits cognition-enhancing activity [3] .
loading...
    loading...
Cat. No.: HY-181961
CAS No.: 3098361-74-8
Target:  

GABA Receptor

Domaines de recherche:  

Cardiovascular Disease Neurological Disease

SR-THAP is a γ-aminobutyric acid transporter 3 (GAT3) inhibitor with an IC50 of 4.9 μM, and exhibits 42-fold and 23-fold selectivity over GAT1 and GlyT1, respectively. SR-THAP inhibits GABA uptake in mammalian cells. SR-THAP is applicable to the research of epilepsy, Alzheimer's disease and ischemic stroke .
loading...
    loading...